168 related articles for article (PubMed ID: 1671361)
1. Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Fertil Steril; 1991 Feb; 55(2):281-6. PubMed ID: 1671361
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenoldopam, a dopamine D-1 receptor agonist, on pituitary, gonadal and thyroid hormone secretion.
Boesgaard S; Hagen C; Andersen AN; Eldrup E; Lange P
Clin Endocrinol (Oxf); 1989 Mar; 30(3):231-9. PubMed ID: 2574081
[TBL] [Abstract][Full Text] [Related]
3. Effect of dopamine and a dopamine D-1 receptor agonist on pulsatile thyrotrophin secretion in normal women.
Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
Clin Endocrinol (Oxf); 1990 Apr; 32(4):423-31. PubMed ID: 1971778
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic inhibition of glycoprotein hormone alpha-subunit in normal subjects.
Boesgaard S; Hagen C; Nyboe Andersen A; Agner T
Metabolism; 1991 Feb; 40(2):150-4. PubMed ID: 1671164
[TBL] [Abstract][Full Text] [Related]
5. Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women.
Boesgaard S; Hagen C; Andersen AN; Fenger M; Eldrup E
Acta Endocrinol (Copenh); 1990 Jan; 122(1):29-36. PubMed ID: 1968308
[TBL] [Abstract][Full Text] [Related]
6. Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
Schoors DF; Dupont AG
Eur J Pharmacol; 1989 Nov; 173(1):109-12. PubMed ID: 2575038
[TBL] [Abstract][Full Text] [Related]
7. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
9. The effect of varying prolactin levels on pituitary luteinizing hormone and follicle-stimulating hormone response to gonadotropin-releasing hormone.
Spellacy WN; Cantor B; Kalra PS; Buhi WC; Birk SA
Am J Obstet Gynecol; 1978 Sep; 132(2):157-64. PubMed ID: 356613
[TBL] [Abstract][Full Text] [Related]
10. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
Hemrika DJ; Slaats EH; Schoemaker J
Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
[TBL] [Abstract][Full Text] [Related]
11. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
[TBL] [Abstract][Full Text] [Related]
12. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
13. Prolactin suppresses GnRH but not TSH secretion.
Page-Wilson G; Smith PC; Welt CK
Horm Res; 2006; 65(1):31-8. PubMed ID: 16357488
[TBL] [Abstract][Full Text] [Related]
14. Effect of epimestrol on gonadotropin and prolactin plasma levels and response to luteinizing hormone-releasing hormone/thyrotropin-releasing hormone in secondary amenorrhea and oligomenorrhea.
Genazzani AR; Facchinetti F; de Leo V; Picciolini E; Franchi F; Parrini D; Kicovic PM
Fertil Steril; 1978 Dec; 30(6):654-60. PubMed ID: 153243
[TBL] [Abstract][Full Text] [Related]
15. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
[TBL] [Abstract][Full Text] [Related]
16. Dopamine: effects on prolactin and luteinizing hormone secretion in ovariectomized rhesus macaques after transection of the pituitary stalk.
Pavasuthipaisit K; Hess DL; Norman RL; Adams TE; Baughman WL; Spies HG
Neuroendocrinology; 1981 Jan; 32(1):42-9. PubMed ID: 7007906
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
18. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
19. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
20. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
